Press Releases
Filters
October 5, 2026
Viatris to Report Third-Quarter 2026 Financial Results on November 5, 2026
September 29, 2026
Viatris Recognized by Forbes as One of the World's Best Employers for the Sixth Consecutive Year
September 16, 2026
Viatris Announces Approval of WAKIX® (Pitolisant) in Japan, a First-in-Class Treatment for Narcolepsy and Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea Syndrome
July 29, 2026
Viatris Receives U.S. FDA Approval for Gwyn Lo™, a Once-Weekly Contraceptive Patch
June 29, 2026
Viatris Announces Positive Top-Line Results from Phase 3 Study of VR-205 in Japanese Adults with Primary Immunoglobulin A Nephropathy
May 18, 2026
U.S. FDA Accepts Viatris New Drug Application for Fast-Acting Meloxicam for the Treatment of Moderate-to-Severe Acute Pain
May 7, 2026
Viatris to Present at the Bank of America Securities 2026 Healthcare Conference
Displaying 1 - 10 of 201
